Oplunofusp

DB15313Investigational

DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).

Also known as
Farbefusp
Code names
DAS-181

Resolves to

Compound
UNII227R1C272QCAS946032-08-2

What you can answer from here — as of October 28, 2025

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Oplunofusp, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In